The Hydropothecary Corporation (“THCX” or the “Company”) (TSX-V:THCX) announced today that it has received approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange (the “TSX-V”) and list its common shares and common share purchase warrants expiring January 30, 2020 on the TSX. The common shares and warrants will commence trading on the TSX effective Friday, June 22, 2018, at which time the Company will also “ring the bell” to open the TSX. In conjunction with listing on TSX, the common shares and warrants will be voluntarily delisted from the TSX-V effective upon commencement of trading on the TSX.
The Hydropothecary Corporation Announces Graduation to the TSX, Shareholder Meeting for Rebranding to HEXO
(Globe Newswire / 2018-06-21)
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis, licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations. We are the only licensed producer headquartered in Quebec. We are currently expanding our facilities to 1.3 million sq. ft., and our production capacity to 108,000 kg of dried cannabis per year.
We create award-winning innovative, easy-to-use and discreet products, while leading the industry as one of the lowest cost producers in the country.
Current Stock Information
HEXO Reaches Supply Agreement with Ontario Cannabis Store
(Globe Newswire / 2018-08-20)
HEXO Celebrates Five Years, 200 Employees … and Growing!
(Globe Newswire / 2018-08-16)
HEXO Applauds the Ontario Governments Proposed Retail Framework
(Globe Newswire / 2018-08-14)
HEXO Harvests First Plants in 250,000 sq. ft. Greenhouse Expansion
(Globe Newswire / 2018-08-09)
Hydropothecary Transfer Agent
TSX Trust Company
301-100 Adelaide Street West
Toronto ON M5H 4H1
Phone: 1-866-393-4891 ext. 205
Investor Relations Contact
The Hydropothecary Corporation
120 chemin de la rive
Gatineau, QC J8M 1V2